The Supreme Court’s long anticipated decision in US v. Arthrex, Inc. is an important rendering for PTAB stakeholders given its potential impact on both past and future IPR proceedings and outcomes. The Court concluded that while PTAB Judges were unconstitutionally appointed as principal officers, but handed the PTO Director the power to review PTAB decisions. Our panel of leading PTAB practitioners will explore the practical implications of this decision. Points of discussion will include:

• Exploring the Supreme Court’s constitutional remedies in US v. Arthrex, Inc.
  • Evaluating the decision’s impact on pending IPR and other proceedings
• Reviewing the decision and its implications for the PTO and PTAB
  • Federal circuit update on supplemental briefings
• Examining how this effects IPR proceedings and the interplay with Federal Courts
• Assessing the PTO Interim Director Review Process post-Arthrex
  • PTAB’s Q&A on Interim Director review process